Abstract:Youjie Zeng, 1 Si Cao, 1 Minghua Chen, 1 Chao Fang, 1, 2 Wen Ouyang 1 1 Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, People's Republic of China; 2 Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, 410013, People's Republic of China Correspondence: Wen Ouyang, Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, People's Republic of China, Email Purpose: To explore the effect of gene polymorphisms of propofol GABA A receptor and metabolic enzyme on drug susceptibility during the induction period of general anesthesia. Patients and Methods: A total of 294 female patients aged 18– 55 years, ASA I–II, who underwent hysteroscopy with intravenous general anesthesia, were included in the study. Anesthesia was induced by continuous intravenous infusion of propofol at 40 mg·kg − 1 ·h − 1 . Infusion of propofol was ended when both the Modified Observer's Assessment of Awareness/Sedation scale (MOAA/S scale) decreased to 1 and the BIS index decreased to 60. The time when the MOAA/S scale decreased to 1 and the time when BIS index decreased to 60 was recorded to assess the susceptibility to the sedation effect. The maximum decreased percentage in mean arterial pressure (MAP) within 5 minutes was recorded to assess the susceptibility of cardiovascular response. Venous blood of each patient was collected to identify the presence of genetic variants in the GABRA1, GABRA2, GABRB2, GABRB3, GABRG2, CYP2B6 , and UGT1A9 genes using the Sequenom MassARRAY ® platform. Results: After receiving propofol infusion, carriers of polymorphic GABRA1 rs4263535 G allele required significantly less time for BIS decreased to 60, while carriers of polymorphic GABRB2 rs3816596 T allele required significantly more time for BIS decreased to 60, carriers of polymorphic GABRA1 rs1157122 C allele and carriers of polymorphic GABRB2 rs76774144 T allele had a significantly less change in MAP. Conclusion: GABRB2 rs3816596 and GABRA1 rs4263535 polymorphisms are associated with susceptibility to the sedation effect of propofol. GABRA1 rs1157122 and GABRB2 rs76774144 polymorphisms are associated with the degree of drop in blood pressure after propofol infusion. Keywords: pharmacogenomics, drug susceptibility, GABA A receptor, CYP2B6 , UGT1A9 Propofol is an intravenous anesthetic that is frequently used for induction of general anesthesia, maintenance of general anesthesia, sedation in the intensive care unit (ICU), and various painless treatments due to its advantages of rapid onset, rapid awakening, and low incidence of postoperative nausea and vomiting. 1 Despite the numerous advantages, propofol can still carry some side effects. Frequent adverse reactions are pain on injection, hypotension, and respiratory depression. 2 In addition, the drug effect of propofol varies with different individuals, even when administered by the same standard. 3 Deep anesthesia will excessively suppress the stress response, leading to severe hypotension and even disrupting the perfusion of vital organs, while inadequate depth of anesthesia will lead to an increased incidence of intraoperative awareness. Therefore, it is important to individualize the medication and give patients the most proper dose to maintain an appropriate depth of anesthesia. Propofol is mainly metabolized in the liver. 4 Seventy percent of propofol bound to uridine diphosphate glucuronosyltransferase 1A9 (UGT1A9) and transform into propofol glucuronide, 29% of propofol is transformed into propofol-4-hydroxypropophol by CYP2B6 and CYP2C9, in which CYP2B6 plays a primary role and CYP2C9 a secondary role. 5 Propofol exerts its sedation effect mainly through activating the GABA A receptor (GABAAR), thereby enhancing the interaction between GABA A and GABAAR. 6 Pharmacogenomics focuses on the relationship between genetic factors and drug response variability. 7 Single nucleotide polymorphism (SNP) refers to a DNA sequence polymorphism caused by a single nucleotide variation that has a prevalence of more than 1% in the population. 8 Pharmacogenomics studies often concern the SNPs related to the pharmacodynamic and pharmacokinetic of certain drugs. Identifying SNPs associated with drug response can help reduce adverse drug reactions, particularly important in patients with poor general conditions. 9</su -Abstract Truncated-

γ-Aminobutyric acid type A receptor β1 subunit gene polymorphisms are associated with the sedative and amnesic effects of midazolam

CYP2A6 and GABRA2 Gene Polymorphisms are Associated With Dexmedetomidine Drug Response

Polymorphisms of pharmacogenetic candidate genes affect etomidate anesthesia susceptibility

GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility

Effects of Vitamin D Receptor, Cytochrome P450 3A, and Cytochrome P450 Oxidoreductase Genetic Polymorphisms on the Pharmacokinetics of Remimazolam in Healthy Chinese Volunteers

Evaluation of the sedative-motor effects of novel GABAkine imidazodiazepines using quantitative observation techniques in rhesus monkeys

The Effects of Gene Variations of GABRA2, GABRB1, GABRG2, GAD1 and SLC1A3 on Patients with Propofol During Anesthesia Induction

The Effects of Variation in the GABAA Receptor Gene on Anxious Depression are Mediated by the Functional Connectivity Between the Amygdala and Middle Frontal Gyrus

CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients

Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

CYP3A4 and CYP2C19 Genetic Polymorphisms and Zolpidem Metabolism in the Chinese Han Population: a Pilot Study.

GABRB1 Single Nucleotide Polymorphism Associated with Altered Brain Responses (but Not Performance) During Measures of Impulsivity and Reward Sensitivity in Human Adolescents.

Association of Gamma-Aminobutyric Acid A Receptor α2 Gene (GABRA2) with Alcohol Use Disorder

Model-based meta-analysis of the effects of non-selective and α 1 -selective GABA A receptor agonists in healthy volunteers

Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression

Systemic vs. central administration of common hypnotics reveals opposing effects on genioglossus muscle activity in rats

Association Between the Use of Midazolam During Cardiac Anesthesia and the Incidence of Postoperative Delirium: A Retrospective Cohort Study Using a Nationwide Database

Mirnas May Regulate GABAergic Transmission Associated Genes in Aged Rats with Anesthetics-Induced Recognition and Working Memory Dysfunction

[The effectiveness of the benzodiazepine antagonist Ro 15-1788 after the induction of anesthesia with midazolam]

Correlation Between Serum and CSF Concentrations of Midazolam and 1-Hydroxy-Midazolam in Critically Ill Neurosurgical Patients

Single- and Multilocus Allelic Variants within the GABAB Receptor Subunit 2 (GABAB2) Gene Are Significantly Associated with Nicotine Dependence